Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Revenue (2016)

Rocket Pharmaceuticals' Revenue history spans 2 years, with the latest figure at -$1.2 million for Q3 2018.

  • For Q3 2018, Revenue changed N/A year-over-year to -$1.2 million; the TTM value through Jun 2019 reached -$1.2 million, changed N/A, while the annual FY2015 figure was -$1.2 million, 25.51% down from the prior year.
  • Revenue for Q3 2018 was -$1.2 million at Rocket Pharmaceuticals, down from $525000.0 in the prior quarter.
  • Across five years, Revenue topped out at $525000.0 in Q4 2016 and bottomed at -$1.2 million in Q3 2018.